{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T19:56:01Z","timestamp":1775764561835,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.schres.2008.11.025","type":"journal-article","created":{"date-parts":[[2009,1,16]],"date-time":"2009-01-16T09:29:53Z","timestamp":1232098193000},"page":"134-142","source":"Crossref","is-referenced-by-count":73,"title":["Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia"],"prefix":"10.1016","volume":"108","author":[{"given":"Mihael H.","family":"Polymeropoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Licamele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendra","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti N.","family":"Mitkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene D.","family":"Carstea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Getoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Lavedan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2008.11.025_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-3057(96)00315-2","article-title":"Tamoxifen prevents sulpiride-induced weight gain in female rats","volume":"57","author":"Baptista","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2008.11.025_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0361-9230(01)00551-2","article-title":"The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects","volume":"56","author":"Carver","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.schres.2008.11.025_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/sj.npp.1300612","article-title":"Microarray analysis of differentially expressed genes in rat frontal cortex under chronic risperidone treatment","volume":"30","author":"Chen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2008.11.025_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S1461145707008048","article-title":"Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex","volume":"11","author":"Cheng","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2008.11.025_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1600-0447.1988.tb06388.x","article-title":"Fat consumption and schizophrenia","volume":"78","author":"Christensen","year":"1988","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2008.11.025_bib64","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.metabol.2006.03.005","article-title":"Effects of raloxifene on lipid and lipoprotein levels in postmenopausal osteoporotic women with and without hypertriglyceridemia","volume":"55","author":"Dayspring","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.schres.2008.11.025_bib6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/YPG.0b013e3283053019","article-title":"Coregulation of genes in the mouse brain following treatment with clozapine, haloperidol, or olanzapine implicates altered potassium channel subunit expression in the mechanism of antipsychotic drug action","volume":"18","author":"Duncan","year":"2008","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.schres.2008.11.025_bib7","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1176\/appi.ajp.159.9.1596","article-title":"Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia","volume":"159","author":"Emsley","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/ajp.2006.163.4.743","article-title":"Time course for antipsychotic treatment response in first-episode schizophrenia","volume":"163","author":"Emsley","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib9","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301002","article-title":"Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique","volume":"31","author":"Fatemi","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2008.11.025_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2202-7-69","article-title":"Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs","volume":"7","author":"Ferno","year":"2006","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.schres.2008.11.025_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1015768114192","article-title":"Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: a dopamine hypothesis","volume":"105","author":"Fornaro","year":"2002","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.schres.2008.11.025_bib12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ajmg.10100","article-title":"Evidence for the multigenic inheritance of schizophrenia","volume":"105","author":"Freedman","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.schres.2008.11.025_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(94)00060-L","article-title":"Increased platelet phospholipase A2 activity in schizophrenia","volume":"16","author":"Gattaz","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2008.11.025_bib14","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/070674370204700504","article-title":"The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women","volume":"47","author":"Grigoriadis","year":"2002","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2350-6-7","article-title":"Theories of schizophrenia: a genetic-inflammatory-vascular synthesis","volume":"6","author":"Hanson","year":"2005","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.schres.2008.11.025_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0272-7358(99)00047-1","article-title":"Why does schizophrenia develop at late adolescence?","volume":"21","author":"Harrop","year":"2001","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.schres.2008.11.025_bib18","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(05)79168-6","article-title":"Fish consumption and major depression","volume":"351","author":"Hibbeln","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2008.11.025_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","article-title":"The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia","volume":"30","author":"Horrobin","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2008.11.025_bib20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0006-3223(91)90235-E","article-title":"Fatty acid levels in the brains of schizophrenics and normal controls","volume":"30","author":"Horrobin","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11745-007-3058-0","article-title":"Membrane fatty acids as pacemakers of animal metabolism","volume":"42","author":"Hulbert","year":"2007","journal-title":"Lipids"},{"key":"10.1016\/j.schres.2008.11.025_bib22","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.mp.4002000","article-title":"Metabolomic mapping of atypical antipsychotic effects in schizophrenia","volume":"12","author":"Kaddurah-Daouk","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0925-4927(01)00081-6","article-title":"Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy: a preliminary study","volume":"106","author":"Komoroski","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2008.11.025_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.psyneuen.2005.11.001","article-title":"A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder","volume":"31","author":"Kulkarni","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2008.11.025_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00048670701732715","article-title":"Hormone modulation: a novel therapeutic approach for women with severe mental illness","volume":"42","author":"Kulkarni","year":"2008","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib26","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.schres.2008.11.025_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/14622416.9.3.289","article-title":"Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial","volume":"9","author":"Lavedan","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.schres.2008.11.025_bib28","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2008.11.025_bib29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/bib\/6.3.298","article-title":"Get ready to GO! A biologist's guide to the Gene Ontology","volume":"6","author":"Lomax","year":"2005","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.schres.2008.11.025_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0092-8674(03)01035-3","article-title":"Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes","volume":"116","author":"Lum","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.schres.2008.11.025_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2006.05.048","article-title":"Cytosolic prostaglandin E2 synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease","volume":"1103","author":"Maida","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2008.11.025_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.schres.2006.11.027","article-title":"Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications","volume":"91","author":"McNamara","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2008.11.025_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0193-953X(18)30173-4","article-title":"Neurodevelopmental pathogenesis of schizophrenia","volume":"16","author":"Nasrallah","year":"1993","journal-title":"Psychiatr. Clin. North Am."},{"issue":"Suppl 4","key":"10.1016\/j.schres.2008.11.025_bib34","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk","volume":"68","author":"Newcomer","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib35","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/gb-2005-6-9-r81","article-title":"L2L: a simple tool for discovering the hidden significance in microarray expression data","volume":"6","author":"Newman","year":"2005","journal-title":"Genome Biol."},{"key":"10.1016\/j.schres.2008.11.025_bib36","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-2275(20)33401-5","article-title":"Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol","volume":"40","author":"Ntambi","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.schres.2008.11.025_bib37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.plefa.2003.08.020","article-title":"Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results","volume":"69","author":"Peet","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.schres.2008.11.025_bib38","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1749936","article-title":"Dopaminergic and ligand-independent activation of steroid hormone receptors","volume":"254","author":"Power","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.schres.2008.11.025_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1742-1241.2000.tb11844.x","article-title":"Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes","volume":"54","author":"Puri","year":"2000","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.schres.2008.11.025_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.mp.4001924","article-title":"Towards a muscarinic hypothesis of schizophrenia","volume":"12","author":"Raedler","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/oxfordjournals.schbul.a007140","article-title":"Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline","volume":"30","author":"Reddy","year":"2004","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2008.11.025_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.plefa.2006.07.014","article-title":"Cultural symbolism of fish and the psychotropic properties of omega-3 fatty acids","volume":"75","author":"Reis","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.schres.2008.11.025_bib43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/11026480310007944","article-title":"The role of omega 3 fatty acids in behaviour, cognition and mood","volume":"47","author":"Richardson","year":"2003","journal-title":"Scand. J. Nutr."},{"key":"10.1016\/j.schres.2008.11.025_bib44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0167-8760(99)00090-2","article-title":"Laterality changes accompanying symptom remission in schizophrenia following treatment with eicosapentaenoic acid","volume":"34","author":"Richardson","year":"1999","journal-title":"Int. J. Psychophysiol."},{"key":"10.1016\/j.schres.2008.11.025_bib45","first-page":"837","article-title":"The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: substrate pellagra","volume":"16","author":"Rudin","year":"1981","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0306-9877(82)90088-3","article-title":"The dominant diseases of modernized societies as omega-3 essential fatty acid deficiency syndrome: substrate beriberi","volume":"8","author":"Rudin","year":"1982","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.schres.2008.11.025_bib47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biopsych.2004.03.019","article-title":"Altered thalamic membrane phospholipids in schizophrenia: a postmortem study","volume":"56","author":"Schmitt","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib49","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.pnpbp.2007.07.004","article-title":"The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study","volume":"31","author":"Sivrioglu","year":"2007","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib50","doi-asserted-by":"crossref","first-page":"14297","DOI":"10.1073\/pnas.2335926100","article-title":"Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db\/db mice","volume":"100","author":"Sleeman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2008.11.025_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biopsych.2004.11.018","article-title":"Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia","volume":"57","author":"Smesny","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.ijo.0801840","article-title":"Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia","volume":"26","author":"Thakore","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.schres.2008.11.025_bib53","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.mp.4001425","article-title":"Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins","volume":"8","author":"Thomas","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11920-007-0041-7","article-title":"Dopamine hypothesis of schizophrenia: making sense of it all","volume":"9","author":"Toda","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.schres.2008.11.025_bib55","first-page":"73","article-title":"Gene\u2013environment interactions in mental disorders","volume":"3","author":"Tsuang","year":"2004","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib56","first-page":"235","article-title":"The epidemiology of schizophrenia","author":"Van Os","year":"2003"},{"key":"10.1016\/j.schres.2008.11.025_bib57","first-page":"1","article-title":"Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients","author":"Vik-Mo","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2008.11.025_bib58","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1194\/jlr.M500454-JLR200","article-title":"Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice","volume":"47","author":"Wang","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.schres.2008.11.025_bib59","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/hmg\/ddn130","article-title":"Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia","volume":"17","author":"Weickert","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.schres.2008.11.025_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0920-9964(99)00095-X","article-title":"Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients","volume":"42","author":"Yao","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2008.11.025_bib61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.plefa.2004.03.011","article-title":"Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia","volume":"71","author":"Yao","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.schres.2008.11.025_bib62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archgenpsychiatry.2007.43","article-title":"Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen","volume":"65","author":"Yildiz","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2008.11.025_bib63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1399-5618.2007.00530.x","article-title":"Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study","volume":"9","author":"Zarate","year":"2007","journal-title":"Bipolar Disord."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996408005306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996408005306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:34:01Z","timestamp":1684859641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996408005306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":64,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0920996408005306"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2008.11.025","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}